Blood Spot Self-administered Test and Assay
NCT03840824 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2020-02-11
Summary
The current study will compare hormone levels of AMH, FSH and inhibin B in blood specimens collected by venipuncture and fingerstick in a sample of pre-menopausal women ages 18-45 years with normal menstrual cycles.
Conditions
- Dysfunction; Endocrine
- Effects of Chemotherapy
- Premature Ovarian Failure
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Clarisa Gracia, MD, MSCE · University of Pennsylvania
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-10-31
- Primary Completion
- 2016-06-30
- Completion
- 2016-08-31
Countries
- United States
Study Locations
More Related Trials
-
Progesterone in Luteal Phase Deficiency
NCT02950948 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral Contraceptives
NCT01291004 ·Status: COMPLETED ·Phase: PHASE1
-
Open-Label Study to Evaluate the Safety and Efficacy of a Low-Dose 28-Day Oral Contraceptive
NCT00362479 ·Status: COMPLETED ·Phase: PHASE3
-
Anti-Mullerian Hormone - At My Home
NCT04784325 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy
NCT01178125 ·Status: COMPLETED ·Phase: PHASE3
-
Longitudinal Hemostatic Profile After Stopping Estroprogestative Contraceptives
NCT03949985 ·Status: COMPLETED
-
Assessing Ovarian Function During Prolonged Implant Use
NCT03058978 ·Status: COMPLETED
-
Assessing the Effect of Multiple Doses of Zibotentan on the Pharmacokinetics of Single Doses of Combined Oral Contraceptives in Healthy Female Participants of Non-childbearing Potential.
NCT05505162 ·Status: COMPLETED ·Phase: PHASE1
-
Investigation of Female Reproductive Hormone Dynamics During Adolescence
NCT02486757 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Metabolic Profile of Users of Hormonal and Non-hormonal Contraceptives
NCT03383185 ·Status: COMPLETED
-
A Multinational Study to Evaluate the Effects of a 28-Day Oral Contraceptive on Hemostatic Parameters in Healthy Women
NCT01388491 ·Status: COMPLETED ·Phase: PHASE2
-
Drug Exposure and Depot Medroxyprogesterone Acetate (DMPA) in Adolescent Subjects
NCT01461824 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 3, Randomized, Three-Cycle, Double-Blind, Placebo-Controlled Study to Evaluate Induction of Secretory Conversion of Endometrium and Withdrawal Bleeding for Secondary Amenorrhea
NCT02019589 ·Status: TERMINATED ·Phase: PHASE3
-
Autologous Platelet Rich Plasma (PRP) Intra Ovarian Infusion in Perimenopausal Women
NCT03951194 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Hormone Replacement for Premature Ovarian Insufficiency
NCT02922348 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of Pregnancy
NCT00996580 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Gynecological Age on LH Sensitivity to Energy Availability
NCT00260286 ·Status: COMPLETED ·Phase: NA
-
Pharmacodynamics and Pharmacokinetics Study of Existing DMPA Contraceptive Methods
NCT02456584 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Vaginal Estrogen on Asymptomatic Microhematuria (AMH)
NCT02213757 ·Status: TERMINATED ·Phase: PHASE4
-
Endometrial Biopsy in Progestin Contraceptive Users
NCT05760144 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Study Comparing Bioavailability of 3 New Formulations of Premarin/MPA With Premarin/MPA (PREMPRO) Reference Formulation
NCT00401219 ·Status: COMPLETED ·Phase: PHASE1
-
US Cycle Control and Blood Pressure Study
NCT00920985 ·Status: COMPLETED ·Phase: PHASE3
-
Endometrial Effects of Daily Progesterone s.c. 25 and 50 Mg Aqueous Formulation to Female Healthy Volunteers
NCT00377923 ·Status: COMPLETED ·Phase: PHASE1
-
A Multi-center, Placebo-controlled Study to Evaluate NT100 in Pregnant Women With a History of Unexplained Recurrent Pregnancy Loss (RPL)
NCT02156063 ·Status: UNKNOWN ·Phase: PHASE2
-
Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer
NCT00033358 ·Status: COMPLETED ·Phase: PHASE2